shall i buy sun pharma at current levels ?

Sun Pharma has always been on a "dream run" and has been perpetually "expensive" for as long as I can remember. This is likely to continue in future as well given the top-quality management and the earnings visibility.

The stock may pause to digest some of the gains it has accumulated before resuming its march. Also, the merger with Ranbaxy could throw up issues that may prove to be a temporary impediment.

Blue chip stocks of such pedigree are meant for "buy and forget" sort of investors. These are like investing in Gilt bonds where you don't have to keep checking the daily situation.

However, there is obviously a price to be paid for that comfort and security. The gains from the stock will probably be moderate compared to that of its smaller peers. That's a choice every investor has to take.

 

There is an article in ET which asks "Sun Pharma ends over 8% down as Daiichi exits; a good buy?"